Frantz EyeCare reported 98% of Light Adjustable Lens patients within ±0.50 D of target but omitted cohort, follow-up, and safety details.
Frantz EyeCare reported refractive outcomes with the Light Adjustable Lens after cataract surgery that exceeded national benchmarks cited by the practice. However, the announcement did not provide the cohort size, follow-up duration, patient characteristics, statistical analyses, or an independently verified data source.¹
The practice reported that 98% of treated patients achieved a manifest refraction spherical equivalent (MRSE) within ±0.50 D of target. It also reported that 96% had residual cylinder within ±0.50 D and 97% achieved sphere within ±0.50 D.¹
"These outcomes reflect what happens when you pair the most advanced technology with experience and individualized care,"said Jonathan Frantz, MD, medical director and chief surgeon of Frantz EyeCare, said in the announcement.¹ “The Light Adjustable Lens lets us fine-tune each patient’s vision after surgery, so the result isn’t just close, it’s customized to them.”
The findings appear to represent practice-level outcomes rather than results from a prospective clinical trial. Frantz EyeCare compared its results with national averages of 94% for MRSE within ±0.50 D and 92% for cylinder within ±0.50 D. The source of these national benchmarks and whether they involved comparable patients, surgeons, follow-up intervals, and measurement protocols were not specified.¹
The practice also cited a retrospective study by John Doane, MD, and colleagues in which approximately 76% of patients receiving the Light Adjustable Lens achieved the specified level of astigmatic precision, compared with roughly half of patients receiving conventional toric lenses. The announcement did not provide a full citation, study population, endpoint timing, or definition of the comparator group, limiting independent assessment of that comparison.¹
No safety findings, adverse-event rates, patient-reported outcomes, or rates of uncorrected visual acuity were reported. The announcement also did not describe enhancement procedures, lens adjustments, exclusions, losses to follow-up, or the proportion of eligible patients included in the analysis.
Residual refractive error after cataract surgery may affect visual quality and continued dependence on spectacles. Unlike an intraocular lens with a fixed refractive power after implantation, the Light Adjustable Lens permits postoperative modification intended to refine the refractive result once the eye has healed.¹ The announcement did not describe the adjustment protocol, number or timing of treatments, patient precautions, or the technology’s regulatory history.
The reported outcomes focus on refractive accuracy rather than broader measures of clinical benefit. MRSE, sphere, and cylinder quantify different components of postoperative refraction, but they do not independently establish spectacle independence, satisfaction, contrast sensitivity, dysphotopsia burden, or functional vision. These outcomes may be particularly relevant when patients are considering premium cataract surgery, but counseling should distinguish refractive predictability from guaranteed glasses-free vision.
The release did not provide details on current alternatives, although it compared the adjustable lens with older toric lens technology. Without a contemporaneous control group, the contribution of lens technology cannot be separated from surgeon experience, biometry, patient selection, ocular comorbidities, or postoperative management.
The practice’s reported rates suggest high refractive predictability within its treated population. Nevertheless, the absence of patient-level methods and peer-reviewed reporting prevents conclusions about statistical significance, generalizability, or superiority over other intraocular lenses.
Additional information is needed regarding sample size, baseline astigmatism, ocular comorbidities, prior refractive surgery, adjustment frequency, follow-up duration, and adverse events. Publication of a defined consecutive cohort, preferably with an appropriate comparator and patient-reported outcomes, would help clarify how the findings apply outside this practice.
